WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006017188) MEMANTINE AS ADJUNCTIVE TREATMENT TO ATYPICAL ANTIPSYCHOTICS IN SCHIZOPHRENIA PATIENTS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/017188    International Application No.:    PCT/US2005/024285
Publication Date: 16.02.2006 International Filing Date: 07.07.2005
IPC:
A61K 31/13 (2006.01), A61P 25/18 (2006.01)
Applicants: FOREST LABORATORIES, INC. [US/US]; 909 Third Avenue, New York, NY 10022-4731 (US) (For All Designated States Except US)
Inventors: JONAS, Jeffery; (US).
GAGE, Allyson; (US)
Agent: SAGE, G., Patrick; The Firm of Hueschen and Sage, Seventh Floor, Kalamazoo Building, 107 West Michigan Avenue, Kalamazoo, MI 49007 (US)
Priority Data:
60/586,553 09.07.2004 US
Title (EN) MEMANTINE AS ADJUNCTIVE TREATMENT TO ATYPICAL ANTIPSYCHOTICS IN SCHIZOPHRENIA PATIENTS
(FR) TRAITEMENT ADJUVANT D’ANTIPSYCHOTIQUES ATYPIQUES À BASE DE MEMANTINE DANS DES CAS DE SCHIZOPHRÉNIE
Abstract: front page image
(EN)The present invention provides a method for treating schizophrenia in a patient in need thereof, the method comprising administering to the patient a therapeutically effective amount of memantine, or a pharmaceutically acceptable salt thereof, and a therapeutically effective amount an atypical antipsychotic. The method of the present invention embodies both the co-administration of memantine with an atypical antipsychotic, and the use of memantine as an adjunctive treatment to treatment with an atypical antipsychotic.
(FR)La présente invention concerne un procédé permettant de traiter la schizophrénie chez un patient le nécessitant, le procédé consiste à administrer au patient une quantité de memantine efficace sur le plan thérapeutique ou d’un sel de celle-ci acceptable sur le plan pharmaceutique et une quantité efficace sur le plan thérapeutique d’antipsychotique atypique. Le procédé de la présente invention regroupe aussi bien la co-administration de la mémantine avec un antipsychotique atypique que l’utilisation de la memantine comme traitement adjuvant au traitement à base d'un antipsychotique atypique.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)